Raiffeisen Bank International AG
BankPosition in BSX — Boston Scientific Corp
CIK 2044885
VIENNA, C4
Position in BSX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$8,390,247
-$4,396,257 QoQ
Shares Held
196,585
-3.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#333
of 1,468 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Raiffeisen Bank International AG holds $99,344,106 across 9 Medical Devices names. BSX ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
93,268 | $29,364,497 | |
| 2 | ABT |
Abbott Laboratories
|
305,266 | $27,699,836 | |
| 3 | EW |
Edwards Lifesciences Corp
|
289,788 | $26,214,222 | |
| 4 | BSX |
Boston Scientific Corp
This page
|
196,585 | $8,390,247 | |
| 5 | MDT |
Medtronic plc
|
64,723 | $5,063,280 | |
| 6 | STE |
STERIS plc
|
5,100 | $1,073,907 | |
| 7 | DXCM |
Dexcom Inc
|
14,266 | $960,815 | |
| 8 | PRCT |
PROCEPT BioRobotics Corp
|
25,000 | $564,500 |
All Filings in BSX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,390,247 | 196,585 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $12,786,504 | 203,769 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $9,201,561 | 96,503 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,139,730 | 93,616 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $10,520,594 | 97,948 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $9,337,856 | 92,564 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $7,904,462 | 88,496 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||